Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2015 Volume 12 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2015 Volume 12 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair

  • Authors:
    • Yong Li
    • Hang Li
    • Wen Peng
    • Xin‑Yun He
    • Min Huang
    • Dong Qiu
    • Ying‑Bo Xue
    • Liang Lu
  • View Affiliations / Copyright

    Affiliations: Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, P.R. China, Department of Occupational and Environmental Health, School of Public Health, Ningxia Medical University, Ningxia 750004, P.R. China
  • Pages: 1328-1334
    |
    Published online on: March 18, 2015
       https://doi.org/10.3892/mmr.2015.3505
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The mechanisms underlying lung cancer radioresistance remain to be fully elucidated. The DNA repair pathway is a predominant target of radiotherapy, which is considered to be involved in the acquired radioresistance of cancer cells. The present study aimed to establish a radioresistant cell model using the A549 human lung cancer cell line, and to further investigate the potential mechanisms underlying the radioresistance. The A549R radioresistant lung cancer cell variant was established by exposing the parental A549 cells to repeated γ‑ray irradiation at a total dose of 60 Gy. Colony formation assays were then used to determine cell survival following γ‑ray exposure. The established radioresistant cells were subsequently treated with or without the NU7026 DNA‑PKcs inhibitor. The levels of DNA damage were determined by counting the number of fluorescent γ‑H2AX foci in the cells. The cellular capacity for DNA repair was assessed using antibodies for the detection of various DNA repair pathway proteins. The radioresistant sub‑clones exhibited significantly decreased survival following NU7026 treatment, compared with the parental cells, as determined by colony formation assays (P<0.05), and this finding was found to be dose‑dependent. Treatment with the DNA‑dependent protein kinase (DNA‑PK) inhibitor significantly reduced γ‑H2AX foci formation (P<0.05) following acute radiation exposure in the radioresistant sub‑clones, compared with the parental control cells. The decreased levels of γ‑H2AX were accompanied by an increase in the percentage of apoptotic cells in the radioresistant cell line following post‑radiation treatment with the DNA‑PKcs inhibitor. The expression levels of proteins associated with the DNA repair pathway were altered markedly in the cells treated with NU7026. The results of the present study suggested that radioresistance may be associated with enhanced DNA repair following exposure to radiation, resulting in reduced apoptosis. Therefore, the quantity of γ‑H2AX determines the radioresistance of cells. The DNA repair pathway is important in mediating radioresistance, and treatment with the DNA‑PKcs inhibitor, NU7026 restored the acquired radiation resistance.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Reck M, Heigener DF, Mok T, Soria JC and Rabe KF: Management of non-small-cell lung cancer: Recent developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Yang HJ, Kim N, Seong KM, Youn H and Youn B: Investigation of radiation-induced transcriptome profile of radioresistant non-small cell lung cancer A549 cells using RNA-seq. PloS One. 8:e593192013. View Article : Google Scholar : PubMed/NCBI

3 

Gupta S, Koru-Sengul T, Arnold SM, Devi GR, Mohiuddin M and Ahmed MM: Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells. Mol Cancer Ther. 10:292–302. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Li J, Yang CX, Mei ZJ, et al: Involvement of cdc25c in cell cycle alteration of a radioresistant lung cancer cell line established with fractionated ionizing radiation. Asian Pac J Cancer Prev. 14:5725–5730. 2013. View Article : Google Scholar : PubMed/NCBI

5 

Kim YS, Kang MJ and Cho YM: Low production of reactive oxygen species and high DNA repair: Mechanism of radio-resistance of prostate cancer stem cells. Anticancer Res. 33:4469–4474. 2013.PubMed/NCBI

6 

Vignard J, Mirey G and Salles B: Ionizing-radiation induced DNA double-strand breaks: a direct and indirect lighting up. Radiother Oncol. 108:362–369. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Beskow C, Skikuniene J, Holgersson A, et al: Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86. Br J Cancer. 101:816–821. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Daido S, Yamamoto A, Fujiwara K, Sawaya R, Kondo S and Kondo Y: Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res. 65:4368–4375. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Negroni A, Stronati L, Grollino MG, Barattini P, Gumiero D and Danesi DT: Radioresistance in a tumour cell line correlates with radiation inducible Ku 70/80 end-binding activity. Int J Radiat Biol. 84:265–276. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Vandersickel V, Mancini M, Slabbert J, et al: The radiosensitizing effect of Ku70/80 knockdown in MCF10A cells irradiated with X-rays and p(66)+Be(40) neutrons. Radiat Oncol. 5:302010. View Article : Google Scholar : PubMed/NCBI

11 

Wang C and Lees-Miller SP: Detection and repair of ionizing radiation-induced DNA double strand breaks: New developments in nonhomologous end joining. Int J Radiat Oncol Biol Phys. 86:440–449. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Khanna KK, Lavin MF, Jackson SP and Mulhern TD: ATM a central controller of cellular responses to DNA damage. Cell Death Differ. 8:1052–1065. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Bakkenist CJ and Kastan MB: DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421:499–506. 2003. View Article : Google Scholar : PubMed/NCBI

14 

Tichy A, Durisova K, Salovska B, et al: Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441. Radiat Environ Biophys. 53:83–92. 2014. View Article : Google Scholar

15 

Keogh MC, Kim JA, Downey M, et al: A phosphatase complex that dephosphorylates gammaH2AX regulates DNA damage checkpoint recovery. Nature. 439:497–501. 2006. View Article : Google Scholar

16 

Leu JD, Chiu YW, Lo CC, et al: Enhanced cellular radio-sensitivity induced by cofilin-1 over-expression is associated with reduced DNA repair capacity. Int J Radiat Biol. 89:433–444. 2013. View Article : Google Scholar : PubMed/NCBI

17 

An J, Huang YC, Xu QZ, et al: DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression. BMC Mol Biol. 11:182010. View Article : Google Scholar : PubMed/NCBI

18 

Du L, Zhou LJ, Pan XJ, et al: Radiosensitization and growth inhibition of cancer cells mediated by an scFv antibody gene against DNA-PKcs in vitro and in vivo. Radiat Oncol. 5:702010. View Article : Google Scholar : PubMed/NCBI

19 

Xiong H, Lee RJ, Haura EB, Edwards JG, Dynan WS and Li S: Intranuclear delivery of a novel antibody-derived radiosensitizer targeting the DNA-dependent protein kinase catalytic subunit. Int J Radiat Oncol Biol Phys. 83:1023–1030. 2012. View Article : Google Scholar

20 

Zhou X, Zhang X, Xie Y, Tanaka K, Wang B and Zhang H: DNA-PKcs inhibition sensitizes cancer cells to carbon-ion irradiation via telomere capping disruption. PLoS One. 8:e726412013. View Article : Google Scholar : PubMed/NCBI

21 

Veuger SJ, Curtin NJ, Richardson CJ, Smith GC and Durkacz BW: Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA -dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res. 63:6008–6015. 2003.PubMed/NCBI

22 

Veuger SJ, Curtin NJ, Smith GC and Durkacz BW: Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair. Oncogene. 23:7322–7329. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Uphoff CC and Drexler HG: Detecting mycoplasma contamination in cell cultures by polymerase chain reaction. Methods Mol Biol. 731:93–103. 2011.PubMed/NCBI

24 

Bristow RG, Jang A, Peacock J, Chung S, Benchimol S and Hill RP: Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene. 9:1527–1536. 1994.PubMed/NCBI

25 

Maroschik B, Gürtler A, Krämer A, et al: Radiation-induced alterations of histone post-translational modification levels in lymphoblastoid cell lines. Radiat Oncol. 9:152014. View Article : Google Scholar : PubMed/NCBI

26 

Djuzenova CS, Elsner I, Katzer A, et al: Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci. Radiat Oncol. 8:982013. View Article : Google Scholar

27 

Fernández MI, Gong Y, Ye Y, et al: γ-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer. Carcinogenesis. 34:2543–2547. 2013. View Article : Google Scholar

28 

Lee SH and Kim CH: DNA-dependent protein kinase complex: A multifunctional protein in DNA repair and damage checkpoint. Mol Cells. 13:159–166. 2002.PubMed/NCBI

29 

Hefferin ML and Tomkinson AE: Mechanism of DNA double-strand break repair by non-homologous end joining. DNA Repair (Amst). 4:639–648. 2005. View Article : Google Scholar

30 

Gil del Alcazar CR, Hardebeck MC, et al: Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma. Clin Cancer Res. 20:1235–1248. 2014. View Article : Google Scholar

31 

Tonotsuka N, Hosoi Y, Miyazaki S, et al: Heterogeneous expression of DNA-dependent protein kinase in esophageal cancer and normal epithelium. Int J Mol Med. 18:441–447. 2006.PubMed/NCBI

32 

Ryu JS, Um JH, Kang CD, et al: Fractionated irradiation leads to restoration of drug sensitivity in MDR cells that correlates with down-regulation of P-gp and DNA-dependent protein kinase activity. Radiat Res. 162:527–535. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Ciszewski WM, Tavecchio M, Dastych J and Curtin NJ: DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin. Breast Cancer Res Treat. 143:47–55. 2014. View Article : Google Scholar

34 

Qu YY, Hu SL, Xu XY, et al: Nimotuzumab enhances the radiosensitivity of cancer cells in vitro by inhibiting radiation-induce d DNA damage repair. Plos one. 8:e707272013. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li Y, Li H, Peng W, He XY, Huang M, Qiu D, Xue YB and Lu L: DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair. Mol Med Rep 12: 1328-1334, 2015.
APA
Li, Y., Li, H., Peng, W., He, X., Huang, M., Qiu, D. ... Lu, L. (2015). DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair. Molecular Medicine Reports, 12, 1328-1334. https://doi.org/10.3892/mmr.2015.3505
MLA
Li, Y., Li, H., Peng, W., He, X., Huang, M., Qiu, D., Xue, Y., Lu, L."DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair". Molecular Medicine Reports 12.1 (2015): 1328-1334.
Chicago
Li, Y., Li, H., Peng, W., He, X., Huang, M., Qiu, D., Xue, Y., Lu, L."DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair". Molecular Medicine Reports 12, no. 1 (2015): 1328-1334. https://doi.org/10.3892/mmr.2015.3505
Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Li H, Peng W, He XY, Huang M, Qiu D, Xue YB and Lu L: DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair. Mol Med Rep 12: 1328-1334, 2015.
APA
Li, Y., Li, H., Peng, W., He, X., Huang, M., Qiu, D. ... Lu, L. (2015). DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair. Molecular Medicine Reports, 12, 1328-1334. https://doi.org/10.3892/mmr.2015.3505
MLA
Li, Y., Li, H., Peng, W., He, X., Huang, M., Qiu, D., Xue, Y., Lu, L."DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair". Molecular Medicine Reports 12.1 (2015): 1328-1334.
Chicago
Li, Y., Li, H., Peng, W., He, X., Huang, M., Qiu, D., Xue, Y., Lu, L."DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair". Molecular Medicine Reports 12, no. 1 (2015): 1328-1334. https://doi.org/10.3892/mmr.2015.3505
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team